Radiotherapy for primary brain tumors in very young children

Area of Science:

• Pediatric Oncology
• Radiation Oncology
• Neuro-oncology

Background:

• Primary intracranial tumors are a significant concern in children under five years old.
• Radiotherapy is a primary treatment modality for these tumors.

Purpose of the Study:

• To evaluate the efficacy of radiotherapy in treating primary intracranial tumors in young children.
• To identify prognostic factors influencing survival rates and long-term outcomes.

Main Methods:

• Retrospective analysis of 91 children under five years treated with radiotherapy for primary intracranial tumors.
• Correlation of tumor type, location, dose, age at diagnosis, and survival rates.
• Assessment of long-term survival and quality of life in survivors.

Main Results:

• Cerebellar astrocytomas and optic chiasm gliomas showed favorable outcomes.
• Brain stem tumors, extensive posterior fossa tumors, and cerebral gliomas had poor prognoses.
• Medulloblastomas, ependymomas, and midbrain tumors had intermediate prognoses.
• A minimum tumor dose of 4000 rad appeared necessary for tumor control.
• Of 63 children diagnosed over five years prior, 43% survived at least five years.
• Most long-term survivors lead normal lives with some mild impairments.

Conclusions:

• Radiotherapy outcomes for pediatric intracranial tumors vary significantly by tumor type and location.
• Age at diagnosis showed a minor correlation with survival, with older children (>24 months) faring slightly better.
• Effective tumor control requires doses of at least 4000 rad, and long-term survivors generally have good quality of life.